These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34667308)

  • 1. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection.
    Andreakos E; Abel L; Vinh DC; Kaja E; Drolet BA; Zhang Q; O'Farrelly C; Novelli G; Rodríguez-Gallego C; Haerynck F; Prando C; Pujol A; ; Su HC; Casanova JL; Spaan AN
    Nat Immunol; 2022 Feb; 23(2):159-164. PubMed ID: 34667308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could the CCR5-Delta32 mutation be protective in SARS-CoV-2 infection?
    Starcevic Cizmarevic N; Kapovic M; Roncevic D; Ristic S
    Physiol Res; 2021 Dec; 70(S2):S249-S252. PubMed ID: 34913355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of aging on host resistance and disease tolerance to SARS-CoV-2 infection.
    Mok DZL; Chan CYY; Ooi EE; Chan KR
    FEBS J; 2021 Sep; 288(17):5055-5070. PubMed ID: 33124149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA repertoire of 115 UAE nationals infected with SARS-CoV-2.
    Alnaqbi H; Tay GK; Jelinek HF; Francis A; Alefishat E; El Haj Chehadeh S; Tahir Saeed A; Hussein M; Laila Salameh ; Mahboub BH; Uddin M; Alkaabi N; Alsafar HS;
    Hum Immunol; 2022 Jan; 83(1):1-9. PubMed ID: 34462158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferons and SARS-CoV-2: from cells to organisms.
    Bastard P; Zhang Q; Zhang SY; Jouanguy E; Casanova JL
    Curr Opin Immunol; 2022 Feb; 74():172-182. PubMed ID: 35149239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors.
    Quarleri J; Delpino MV
    Cytokine Growth Factor Rev; 2021 Apr; 58():55-65. PubMed ID: 33608189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.
    Casanova JL; Su HC;
    Cell; 2020 Jun; 181(6):1194-1199. PubMed ID: 32405102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection-induced inflammation from specific inborn errors of immunity to COVID-19.
    Ku CL; Chen IT; Lai MZ
    FEBS J; 2021 Sep; 288(17):5021-5041. PubMed ID: 33971084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity.
    Cuesta-Llavona E; Gómez J; Albaiceta GM; Amado-Rodríguez L; García-Clemente M; Gutiérrez-Rodríguez J; López-Alonso I; Hermida T; Enríquez AI; Hernández-González C; Gil-Peña H; Domínguez-Garrido E; Pérez-Oliveira S; Alvarez V; López-Larrea C; Suarez-Alvarez B; Tranche S; Jimeno-Demuth FJ; Coto E
    Int Immunopharmacol; 2021 Sep; 98():107825. PubMed ID: 34116286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19.
    Zepeda-Cervantes J; Martínez-Flores D; Ramírez-Jarquín JO; Tecalco-Cruz ÁC; Alavez-Pérez NS; Vaca L; Sarmiento-Silva RE
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR5Delta32 deletion as a protective factor in Czech first-wave COVID-19 subjects.
    Hubacek JA; Dusek L; Majek O; Adamek V; Cervinkova T; Dlouha D; Pavel J; Adamkova V
    Physiol Res; 2021 Mar; 70(1):111-115. PubMed ID: 33728925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.
    Wang K; Chen W; Zhang Z; Deng Y; Lian JQ; Du P; Wei D; Zhang Y; Sun XX; Gong L; Yang X; He L; Zhang L; Yang Z; Geng JJ; Chen R; Zhang H; Wang B; Zhu YM; Nan G; Jiang JL; Li L; Wu J; Lin P; Huang W; Xie L; Zheng ZH; Zhang K; Miao JL; Cui HY; Huang M; Zhang J; Fu L; Yang XM; Zhao Z; Sun S; Gu H; Wang Z; Wang CF; Lu Y; Liu YY; Wang QY; Bian H; Zhu P; Chen ZN
    Signal Transduct Target Ther; 2020 Dec; 5(1):283. PubMed ID: 33277466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common Genetic Variation in Humans Impacts In Vitro Susceptibility to SARS-CoV-2 Infection.
    Dobrindt K; Hoagland DA; Seah C; Kassim B; O'Shea CP; Murphy A; Iskhakova M; Fernando MB; Powell SK; Deans PJM; Javidfar B; Peter C; Møller R; Uhl SA; Garcia MF; Kimura M; Iwasawa K; Crary JF; Kotton DN; Takebe T; Huckins LM; tenOever BR; Akbarian S; Brennand KJ
    Stem Cell Reports; 2021 Mar; 16(3):505-518. PubMed ID: 33636110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 in Children with Asthma.
    Chatziparasidis G; Kantar A
    Lung; 2021 Feb; 199(1):7-12. PubMed ID: 33496842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
    Schuhenn J; Meister TL; Todt D; Bracht T; Schork K; Billaud JN; Elsner C; Heinen N; Karakoese Z; Haid S; Kumar S; Brunotte L; Eisenacher M; Di Y; Lew J; Falzarano D; Chen J; Yuan Z; Pietschmann T; Wiegmann B; Uebner H; Taube C; Le-Trilling VTK; Trilling M; Krawczyk A; Ludwig S; Sitek B; Steinmann E; Dittmer U; Lavender KJ; Sutter K; Pfaender S
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35131898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting human population variation in single-cell responses to SARS-CoV-2.
    Aquino Y; Bisiaux A; Li Z; O'Neill M; Mendoza-Revilla J; Merkling SH; Kerner G; Hasan M; Libri V; Bondet V; Smith N; de Cevins C; Ménager M; Luca F; Pique-Regi R; Barba-Spaeth G; Pietropaoli S; Schwartz O; Leroux-Roels G; Lee CK; Leung K; Wu JT; Peiris M; Bruzzone R; Abel L; Casanova JL; Valkenburg SA; Duffy D; Patin E; Rotival M; Quintana-Murci L
    Nature; 2023 Sep; 621(7977):120-128. PubMed ID: 37558883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection.
    Klaassen K; Stankovic B; Zukic B; Kotur N; Gasic V; Pavlovic S; Stojiljkovic M
    Infect Genet Evol; 2020 Oct; 84():104498. PubMed ID: 32771700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selected inherited factors on susceptibility to SARS-CoV-2 infection and COVID-19 progression.
    Hubacek JA
    Physiol Res; 2021 Dec; 70(S2):S125-S134. PubMed ID: 34913347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity.
    Tangye SG; Bucciol G; Meyts I
    Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):515-524. PubMed ID: 34494617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons
    Luo W; Huang L; Wang X; Ma Y; Xiao J; Song X; Liu P; Wang Y; Wang Y; Ren Z
    Int J Med Sci; 2021; 18(12):2561-2569. PubMed ID: 34104087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.